SC O TLAND
Scotland’s Booming HealthTech Sector
Scotland’s life sciences sector is globally renowned thanks to our incredible workforce, world-class universities and innovative companies that are located here.
We are proud that a wide range of businesses providing solutions to the global HealthTech market have chosen to call Scotland their home. These not only include multinationals such as Medtronic, Canon Medical Research Europe and Terumo Aortic, but also many highly innovative small and medium sized enterprises. The sector has a highly skilled workforce that consistently delivers innovation, including: n Pillcam, an edible miniature camera that checks for signs of colon cancer
n The world’s first commercially available multi- articulated prosthetic hand developed by Touch Bionics
n The manufacture of LumiraDx’s 12-minute COVID-19 antigen testing strips
n The world’s first MRI scanner developed at the University of Aberdeen
In total, there are more than 250 companies in Scotland’s HealthTech sector, ensuring that is strategically important to our life sciences industry. A great example is Current Health,
headquartered in Edinburgh, which has developed an all-in-one monitoring device that continuously and passively monitors patient health remotely with the same accuracy as an ICU monitor. Following co-investment from Scottish Enterprise, alongside Scottish Co-investment Fund partner Par Equity in 2017, Current Health was acquired by US-based Best Buy for $400m. This significantly
10 UKHEALTHCARE P A VILION. COM
enhanced the company’s ability to expand at scale and grow its Scottish and US-based team. Scotland is also well positioned to take
advantage of the growing digital health market, with more than 200 innovative companies already providing digital solutions for improved health across the globe in areas such as: n Data-driven solutions n Artificial Intelligence in Health Connected Health.
n eHealth
With a population of just more than five million, Scotland has a highly developed health informatics system, with picture archiving and a unique identifier for every patient (Community Health Index or CHI). This provides an invaluable longitudinal data resource for clinical studies, enhanced product development and approval. Additionally, Scotland’s diverse geography
across urban, rural, and remote locations creates relevant test beds for product development. Scotland also provides an environment for
DUSSELDORF 2022
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52
